| |
Immuo-Oncology Antibodies in the News
June 2020
Corvus Pharmaceuticals is optimising a lead anti-CXCR2 antibody for cancer therapy.
May 2017
Corvus Pharmaceuticals licensed an immuno-oncology program from Monash University.
Anti-C5aR Antibody in the News
April 2020
Innate Pharma commenced a trial of its anti-C5aR antibody in COVID-19 patients.
September 2018
Innate Pharma commenced a trial of its anti-C5aR antibody in patients with solid tumours.
June 2017
Innate Pharma acquired an anti-C5aR antibody from Novo Nordisk A/S with plans to conduct clinical trials in oncology indications.
October 22, 2008
G2 & Novo Nordisk A/S announce the start of clinical trials (pdf, 100k)
February 8, 2006
G2 & Novo Nordisk A/S announce US$102m collaboration (pdf, 100k)
|
|
